In Episode 2 of Unlocking Antiarrhythmics From ABCs to Action, #HRStv host Deepthy Varghese, DNP, ACNP, FNP is joined by Jose L. Merino, MD, PhD to explore what it means to truly personalize antiarrhythmic drug (AAD) therapy across diverse patient populations. Together, they discuss real-world strategies for tailoring treatment based on age, comorbidities, arrhythmia type, and individual risk factors — highlighting how precision medicine is reshaping rhythm management. From dosing considerations to emerging research and clinical challenges, viewers will gain actionable insight to help optimize AAD use in varied care settings and deliver more confident, patient-centered treatment.

Stay tuned for Episode 3: Wearables and AADs: Next-Gen Rhythm Monitoring at Home

Additional Resources

https://academic.oup.com/europace/article/27/8/euaf076/8100306?login=true

https://www.jacc.org/doi/10.1016/j.jacep.2024.11.020

Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].

In this Breaking News conversation, #HRStv host Daniel M. Alyesh, MD, FHRS, is joined by Melanie Gunawardene, MD, FHRS, and Julian Chun, MD, to discuss a recent Circulation Research Letter describing life-threatening delayed myocardial ischemia and arrhythmias following PFA for AFib. They explore the proposed mechanisms and its correlation with the MANIFEST US study, as well as comparisons with thermal ablation data.

Additional Resources

Circulation. 2026;153:00–00. DOI: 10.1161/CIRCULATIONAHA.125.077983
Turagam, M, Aryana, A, Day, J. et al. Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients: MANIFEST-US. JACC. null2025, 0 (0)
Circ Arrhythm Electrophysiol. 2023;16:e011365. DOI: 10.1161/CIRCEP.122.011365

Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].

Unlocking Antiarrhythmics From ABCs to Action is a new 3-part series designed to strengthen foundational knowledge and support real-world clinical decision-making for allied professionals.

From the basics to advanced strategies, this episode breaks down antiarrhythmic drug classes, safety considerations, and how to personalize therapy across diverse patient populations — including the latest on outpatient sotalol and wearable heart monitoring.

#HRStv host Deepthy Varghese, DNP, ACNP, FNP is joined by Megan Labreck, PharmD, and Rachel Schreier, MSN, ACNP, APRN for a practical, clinically focused discussion to support confident patient care.

Stay tuned for Episodes 2 and 3:

Episode 2: Real-World Rhythm — Personalizing AADs Across Populations

Episode 3: Wearables and AADs: Next-Gen Rhythm Monitoring at Home

Additional Resources

https://academic.oup.com/europace/advance-article/doi/10.1093/europace/euaf076/8100306

https://www.jacc.org/doi/abs/10.1016/j.jacep.2024.11.020

https://www.jacc.org/doi/abs/10.1016/j.jacep.2024.10.003

https://www.sciencedirect.com/science/article/pii/S2666501824001478

Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].

Roderick Tung, MD, FHRS, talks with Amit J. Shanker, MD, FHRS, author of "HRS/ACC scientific statement: Guiding principles on the performance of intracardiac ablation procedures in ambulatory surgical centers", which published in the January 2026 issue of Heart Rhythm.

Additional Resources

Article: https://www.heartrhythmjournal.com/article/S1547-5271(25)02874-7/fulltext

Issue: https://www.heartrhythmjournal.com/issue/S1547-5271(25)X0013-8

Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].

In this episode of Left to Our Own Devices, #HRStv host Oliver J. Monfredi, MBChB, PhD, FHRS is joined by Jurgen Kuschyk, MD, PhD for a clinician-focused introduction to CCM therapy, highlighting key developments, evolving indications, and practical considerations based on 2025 clinical insights and experience.

Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].

The Heart Rhythm Society announced plans to develop a first-of-its-kind Pulsed Field Ablation data collection platform (registry), sponsored in part by Johnson & Johnson MedTech, a global leader in the treatment of heart rhythm disorders. The platform will offer a national, technology-enabled infrastructure designed to advance clinical evidence, improve patient outcomes, and support post-market surveillance for atrial fibrillation PFA procedures.

Read the full press release here: https://bit.ly/4qijiQQ

Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].

In this new Global EP episode, Prashanthan Sanders, MBBS, PhD, FHRS is joined by Minglong Chen, MD, PhD to highlight exciting developments on PFA in China.

Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].

The Heart Rhythm Society is pleased to announce Christina Wurster, MBA, CAE, as its next Chief Executive Officer. In this conversation, Christina reflects on her previous 12 years with HRS, her leadership as CEO of the Society for Maternal-Fetal Medicine (SMFM), and what excites her about returning to HRS and the field of electrophysiology.

Read the full press release here: https://www.hrsonline.org/news/new-hrs-ceo-march-2026/?utm_source=youtube&utm_medium=social&utm_campaign=press_release&utm_content=CEO_announcement

Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].